Cyclerion Therapeutics In...
3.00
0.08 (2.74%)
At close: Jan 15, 2025, 3:59 PM
3.01
0.40%
After-hours Jan 15, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -5.26M -44.08M -51.65M -77.80M -123.01M -115.25M -93.92M -63.55M
Depreciation & Amortization n/a 65.00K 472.00K 2.30M 2.70M 1.53M 1.75M 2.17M
Stock-Based Compensation 1.07M 6.25M 9.61M 14.99M 19.63M 12.43M 9.49M n/a
Other Working Capital -2.92M -4.00M 988.00K -3.49M 2.61M 2.81M 1.07M 3.82M
Other Non-Cash Items -12.45M 5.24M 881.00K -1.67M 751.00K 14.51M 12.59M 11.02M
Deferred Income Tax n/a -5.24M 2.76M -2.72M n/a n/a n/a n/a
Change in Working Capital -4.60M -2.85M 1.41M -7.59M -2.29M 3.79M 1.47M 4.33M
Operating Cash Flow -21.25M -40.61M -36.52M -72.49M -102.22M -97.50M -81.22M -49.87M
Capital Expenditures n/a n/a -7.00K -1.52M -6.89M -3.44M -1.40M -1.45M
Acquisitions n/a n/a 1.46M 1.54M 173.00K n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies 10.40M n/a 1.46M 1.54M 173.00K n/a n/a n/a
Investing Cash Flow 10.40M n/a 1.46M 18.00K -6.71M -3.44M -1.40M -1.45M
Debt Repayment n/a n/a n/a 3.51M n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 5.02M 29.00K 282.00K 331.00K 36.57M 100.94M 82.62M 51.32M
Financial Cash Flow 5.02M 29.00K 30.79M 28.09M 211.57M 100.94M 82.62M 51.32M
Net Cash Flow -5.81M -40.58M -4.27M -44.39M 102.62M n/a n/a n/a
Free Cash Flow -21.25M -40.61M -36.52M -74.01M -109.10M -100.94M -82.62M -51.32M